122 related articles for article (PubMed ID: 28551626)
1. Lipoic Acid Decreases the Viability of Breast Cancer Cells and Activity of PTP1B and SHP2.
Kuban-Jankowska A; Gorska-Ponikowska M; Wozniak M
Anticancer Res; 2017 Jun; 37(6):2893-2898. PubMed ID: 28551626
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory Activity of Iron Chelators ATA and DFO on MCF-7 Breast Cancer Cells and Phosphatases PTP1B and SHP2.
Kuban-Jankowska A; Sahu KK; Gorska-Ponikowska M; Tuszynski JA; Wozniak M
Anticancer Res; 2017 Sep; 37(9):4799-4806. PubMed ID: 28870898
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of small peptide compounds, molecular docking, and inhibitory activity evaluation against phosphatases PTP1B and SHP2.
Kostrzewa T; Sahu KK; Gorska-Ponikowska M; Tuszynski JA; Kuban-Jankowska A
Drug Des Devel Ther; 2018; 12():4139-4147. PubMed ID: 30584278
[TBL] [Abstract][Full Text] [Related]
4. Ethacrynic acid inhibits STAT3 activity through the modulation of SHP2 and PTP1B tyrosine phosphatases in DU145 prostate carcinoma cells.
Lee YJ; Song H; Yoon YJ; Park SJ; Kim SY; Cho Han D; Kwon BM
Biochem Pharmacol; 2020 May; 175():113920. PubMed ID: 32201212
[TBL] [Abstract][Full Text] [Related]
5. PTP1B phosphatase as a novel target of oleuropein activity in MCF-7 breast cancer model.
Przychodzen P; Kuban-Jankowska A; Wyszkowska R; Barone G; Bosco GL; Celso FL; Kamm A; Daca A; Kostrzewa T; Gorska-Ponikowska M
Toxicol In Vitro; 2019 Dec; 61():104624. PubMed ID: 31419504
[TBL] [Abstract][Full Text] [Related]
6. Docosahexaenoic Acid Inhibits PTP1B Phosphatase and the Viability of MCF-7 Breast Cancer Cells.
Kuban-Jankowska A; Gorska-Ponikowska M; Sahu KK; Kostrzewa T; Wozniak M; Tuszynski J
Nutrients; 2019 Oct; 11(11):. PubMed ID: 31652764
[TBL] [Abstract][Full Text] [Related]
7. PTP1B suppresses prolactin activation of Stat5 in breast cancer cells.
Johnson KJ; Peck AR; Liu C; Tran TH; Utama FE; Sjolund AB; Schaber JD; Witkiewicz AK; Rui H
Am J Pathol; 2010 Dec; 177(6):2971-83. PubMed ID: 20952588
[TBL] [Abstract][Full Text] [Related]
8. Curcumin and Cinnamaldehyde as PTP1B Inhibitors With Antidiabetic and Anticancer Potential.
Kostrzewa T; Przychodzen P; Gorska-Ponikowska M; Kuban-Jankowska A
Anticancer Res; 2019 Feb; 39(2):745-749. PubMed ID: 30711953
[TBL] [Abstract][Full Text] [Related]
9. Benzo[c][1,2,5]thiadiazole derivatives: A new class of potent Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitors.
Wang WL; Chen XY; Gao Y; Gao LX; Sheng L; Zhu J; Xu L; Ding ZZ; Zhang C; Li JY; Li J; Zhou YB
Bioorg Med Chem Lett; 2017 Dec; 27(23):5154-5157. PubMed ID: 29100798
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibitors of the protein tyrosine phosphatase SHP2 block cellular motility and growth of cancer cells in vitro and in vivo.
Grosskopf S; Eckert C; Arkona C; Radetzki S; Böhm K; Heinemann U; Wolber G; von Kries JP; Birchmeier W; Rademann J
ChemMedChem; 2015 May; 10(5):815-26. PubMed ID: 25877780
[TBL] [Abstract][Full Text] [Related]
11. Protein tyrosine phosphatase 1B expression contributes to the development of breast cancer.
Liao SC; Li JX; Yu L; Sun SR
J Zhejiang Univ Sci B; 2017 Apr.; 18(4):334-342. PubMed ID: 28378571
[TBL] [Abstract][Full Text] [Related]
12. Alpha lipoic acid inhibits human T-cell migration: implications for multiple sclerosis.
Marracci GH; McKeon GP; Marquardt WE; Winter RW; Riscoe MK; Bourdette DN
J Neurosci Res; 2004 Nov; 78(3):362-70. PubMed ID: 15389837
[TBL] [Abstract][Full Text] [Related]
13. The pharmacology of the antioxidant lipoic acid.
Biewenga GP; Haenen GR; Bast A
Gen Pharmacol; 1997 Sep; 29(3):315-31. PubMed ID: 9378235
[TBL] [Abstract][Full Text] [Related]
14. Synergic prooxidant, apoptotic and TRPV1 channel activator effects of alpha-lipoic acid and cisplatin in MCF-7 breast cancer cells.
Nur G; Nazıroğlu M; Deveci HA
J Recept Signal Transduct Res; 2017 Dec; 37(6):569-577. PubMed ID: 28849985
[TBL] [Abstract][Full Text] [Related]
15. The natural antioxidant alpha-lipoic acid induces p27(Kip1)-dependent cell cycle arrest and apoptosis in MCF-7 human breast cancer cells.
Dozio E; Ruscica M; Passafaro L; Dogliotti G; Steffani L; Marthyn P; Pagani A; Demartini G; Esposti D; Fraschini F; Magni P
Eur J Pharmacol; 2010 Sep; 641(1):29-34. PubMed ID: 20580704
[TBL] [Abstract][Full Text] [Related]
16. Estrogens and PTP1B function in a novel pathway to regulate aromatase enzymatic activity in breast cancer cells.
Barone I; Giordano C; Malivindi R; Lanzino M; Rizza P; Casaburi I; Bonofiglio D; Catalano S; Andò S
Endocrinology; 2012 Nov; 153(11):5157-66. PubMed ID: 22962253
[TBL] [Abstract][Full Text] [Related]
17. alpha-Lipoic acid induces apoptosis in human colon cancer cells by increasing mitochondrial respiration with a concomitant O2-*-generation.
Wenzel U; Nickel A; Daniel H
Apoptosis; 2005 Mar; 10(2):359-68. PubMed ID: 15843897
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of Protein Tyrosine Phosphatase PTP1B With Anticancer Potential.
Kostrzewa T; Styszko J; Gorska-Ponikowska M; Sledzinski T; Kuban-Jankowska A
Anticancer Res; 2019 Jul; 39(7):3379-3384. PubMed ID: 31262859
[TBL] [Abstract][Full Text] [Related]
19. The Discovery of Potent SHP2 Inhibitors with Anti-Proliferative Activity in Breast Cancer Cell Lines.
Ghemrawi R; Khair M; Hasan S; Aldulaymi R; AlNeyadi SS; Atatreh N; Ghattas MA
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457286
[TBL] [Abstract][Full Text] [Related]
20. Dihydrolipoic acid inhibits tetrachlorohydroquinone-induced tumor promotion through prevention of oxidative damage.
Wang YJ; Yang MC; Pan MH
Food Chem Toxicol; 2008 Dec; 46(12):3739-48. PubMed ID: 18951944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
